109 results
Page 4 of 6
DEFA14A
9n8oboe140lz
9 Jun 22
Additional proxy soliciting materials
9:06am
8-K
pwu3 pjtx2d
2 Jun 22
Cost Associated with Exit or Disposal Activities
6:33am
8-K
EX-99.2
yml1g249
2 Jun 22
Cost Associated with Exit or Disposal Activities
6:33am
8-K
EX-99.1
6h0c4a
2 Jun 22
Cost Associated with Exit or Disposal Activities
6:33am
DEF 14A
1k42s
23 May 22
Definitive proxy
8:00am
8-K
EX-99.1
qy7xvg
16 May 22
Centessa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Updates
7:14am
10-K/A
8ato4a5latniofre3f
2 May 22
Annual report (amended)
4:30pm
8-K
EX-99.1
w4m80 vquw9nx0
30 Mar 22
Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update
4:06pm
8-K
EX-99.2
x6k gk6nupjs65z
30 Mar 22
Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update
4:06pm
10-K
EX-10.35
afixh5imtwssz
30 Mar 22
Annual report
12:00am
10-K
qv4aw0jp k638a7nqg
30 Mar 22
Annual report
12:00am
8-K/A
EX-99.1
ksvks xox6
14 Mar 22
Unregistered Sales of Equity Securities
7:38am
8-K
EX-99.1
pubeu01qh12ye 5x
24 Feb 22
Unregistered Sales of Equity Securities
7:37am
8-K
EX-99.1
w8c0f1dzyi24
14 Dec 21
Regulation FD Disclosure
7:58am
8-K
dol f5wnfdmb5f18domt
14 Dec 21
Regulation FD Disclosure
7:58am
8-K
EX-99.1
jtbv11
15 Nov 21
Centessa Pharmaceuticals Announces Third Quarter 2021 Financial Results and Business Updates
7:11am
8-K
EX-99.2
l86 8e5xgde64hd
1 Nov 21
Regulation FD Disclosure
7:38am